Skip to content

A cross-sectional study on the characteristics and distribution of acupoint sensitization in patients with chronic coronary syndrome

A cross-sectional study on the characteristics and distribution of acupoint sensitization in patients with chronic coronary syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000102
Enrollment
Unknown
Registered
2024-06-18
Start date
2023-05-19
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic coronary syndrome

Interventions

Patients with chronic coronary syndrome:Detection of sensitization
health volunteer:Detection of sensitization

Sponsors

Shaanxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: For patients with chronic coronary syndromes: (1) meet the diagnostic criteria of chronic coronary syndrome; (2) Patients were not limited in activity, with clear answers and good compliance; (3) 18= 85 years old, male or female; (4) those who voluntarily signed the informed consent; Healthy subjects: (1) 18= age =85 years old, male or female; (2) no history of chronic coronary syndrome or other heart diseases; (3) No obvious discomfort symptoms, clear answers, good compliance; (4) those who voluntarily signed the informed consent;

Exclusion criteria

Exclusion criteria: For patients with chronic coronary syndromes: (1) there are serious arrhythmia, heart failure, valvular heart disease, congenital heart disease, primary cardiomyopathy, aortic dissection, and other heart disease, and patients with severe cerebrovascular disease; (2) patients with malignant tumors, severe hematological diseases, severe liver and kidney dysfunction, and mental disorders who are unable to cooperate; (3) has a tendency to bleeding or allergic constitution; (4) patients with severe osteoporosis; (5) pain in shoulder, back and arm caused by muscle strain, myofasciitis, cervical spine and thoracic spine lesions; (6) detection area skin damage of the operator, (7) pregnant and lactating women; (8) those who participated or are participating in other clinical trials within the past 3 months. Healthy subjects: (1) during pregnancy and lactation women; (2) the skin damage of the exploration area affects the operator; (3) for nearly three months had attended or is in other clinical subjects.

Design outcomes

Primary

MeasureTime frame
Skin morphological changes;pressure pain threshold;skin temperature;

Countries

China

Contacts

Public ContactQiao Haifa

Shaanxi University of Chinese Medicine

1511006@sntcm.edu.cn18220046518

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026